DiaMedica Therapeutics DMAC
NASDAQ DMAC
$8.27 +0.07 (+0.85%)
At close: Sep 30, 2026 · 4:00 PM EDT

DiaMedica Therapeutics (DMAC) Capital Expenditures (2018 - 2026)

Updated

DiaMedica Therapeutics (DMAC) recorded Capital Expenditures of $3,000 in Q2 2026, down 50.0% from $6,000 a year earlier and down 62.5% from the prior quarter.

Analysis

DiaMedica Therapeutics (DMAC) Capital Expenditures (2018 - 2026) Analysis & Trends

On a TTM basis, DiaMedica Therapeutics' Capital Expenditures came in at $33,000 as of Jun 30, 2026, down 2.9% year-over-year; for FY2025, it was $40,000, up 60.0% from FY2024.

  • Annual Capital Expenditures has a five-year compound annual growth rate of -3.2% (FY2020 to FY2025).
  • Across earlier years, Capital Expenditures came in at $25,000 in FY2024 (+4.2%), $24,000 in FY2023 (-70.4%), $81,000 in FY2022 (+268.2%) and $22,000 in FY2021 (-53.2%).
  • Quarterly Capital Expenditures has ranged from $2,000 in Q3 2021 to $43,000 in Q3 2022 over the past five years.
  • On a year-over-year basis, Capital Expenditures has declined for three consecutive quarters, with growth averaging 19.5% over the last seven quarters.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 357.1% in Q4 2022, against a decline of 90.6% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $8,000 (Q1 2026), $6,000 (Q4 2025) and $16,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 DiaMedica Therapeutics 445.97 Mn 445.97 Mn - 3,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3,000.00
Mar 31, 2026 8,000.00
Dec 31, 2025 6,000.00
Sep 30, 2025 16,000.00
Jun 30, 2025 6,000.00
Mar 31, 2025 12,000.00
Dec 31, 2024 7,000.00
Sep 30, 2024 9,000.00
Mar 31, 2024 9,000.00
Dec 31, 2023 3,000.00
Sep 30, 2023 10,000.00
Jun 30, 2023 4,000.00
Mar 31, 2023 7,000.00
Dec 31, 2022 32,000.00
Sep 30, 2022 43,000.00
Jun 30, 2022 6,000.00
Dec 31, 2021 7,000.00
Sep 30, 2021 2,000.00
Jun 30, 2021 4,000.00
Mar 31, 2021 9,000.00
API Access

DiaMedica Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DMAC&period=max&api_key=YOUR_API_KEY